全文获取类型
收费全文 | 3083篇 |
免费 | 96篇 |
国内免费 | 53篇 |
专业分类
耳鼻咽喉 | 106篇 |
儿科学 | 25篇 |
基础医学 | 479篇 |
口腔科学 | 73篇 |
临床医学 | 187篇 |
内科学 | 158篇 |
皮肤病学 | 6篇 |
神经病学 | 109篇 |
特种医学 | 320篇 |
外科学 | 1337篇 |
综合类 | 241篇 |
预防医学 | 28篇 |
眼科学 | 6篇 |
药学 | 87篇 |
1篇 | |
中国医学 | 45篇 |
肿瘤学 | 24篇 |
出版年
2023年 | 37篇 |
2022年 | 83篇 |
2021年 | 101篇 |
2020年 | 78篇 |
2019年 | 93篇 |
2018年 | 94篇 |
2017年 | 87篇 |
2016年 | 68篇 |
2015年 | 78篇 |
2014年 | 222篇 |
2013年 | 192篇 |
2012年 | 116篇 |
2011年 | 137篇 |
2010年 | 124篇 |
2009年 | 148篇 |
2008年 | 149篇 |
2007年 | 151篇 |
2006年 | 112篇 |
2005年 | 141篇 |
2004年 | 129篇 |
2003年 | 97篇 |
2002年 | 80篇 |
2001年 | 60篇 |
2000年 | 65篇 |
1999年 | 41篇 |
1998年 | 51篇 |
1997年 | 40篇 |
1996年 | 41篇 |
1995年 | 29篇 |
1994年 | 28篇 |
1993年 | 19篇 |
1992年 | 33篇 |
1991年 | 23篇 |
1990年 | 22篇 |
1989年 | 24篇 |
1988年 | 25篇 |
1987年 | 22篇 |
1986年 | 16篇 |
1985年 | 29篇 |
1984年 | 24篇 |
1983年 | 16篇 |
1982年 | 17篇 |
1981年 | 10篇 |
1980年 | 12篇 |
1979年 | 10篇 |
1978年 | 7篇 |
1977年 | 9篇 |
1972年 | 7篇 |
1971年 | 6篇 |
1970年 | 10篇 |
排序方式: 共有3232条查询结果,搜索用时 31 毫秒
1.
目的观察脐带间充质干细胞分泌的外泌体对骨性关节炎模型大鼠疼痛行为、软骨修复及背根神经节(DRG)中转录激活因子3(ATF-3)及生长相关蛋白43(GAP-43)表达的影响, 并探讨外泌体治疗关节炎疼痛的可能机制。方法采用随机数字表法将54只雄性SD大鼠分为假手术组、模型组和外泌体组, 每组18只, 除假手术组外, 其余2组均于左后肢膝关节腔注射4 mg/50 μl单碘乙酸钠(MIA)建立疼痛模型, 假手术组大鼠关节腔注射50 μl生理盐水作为对照。造模14天后, 假手术组和模型组大鼠左后肢膝关节腔注射50 μl生理盐水, 外泌体组大鼠注射50 μl外泌体。于造模前1天、造模后第7、14天及给药后第7、14、28天对各组大鼠机械痛阈和热痛阈进行测定;于测试后取出相应时间点DRG, 采用免疫蛋白印迹法检测ATF-3及GAP-43表达情况;并取出相应时间点各组大鼠膝关节, 采用苏木素伊红(HE)染色检测软骨修复情况。结果与模型组比较, 外泌体组在给药后第7天时, 机械痛阈值及热痛阈值均明显增加, 直到给药后第28天时差异均具有统计学意义(P<0.05);DRG水平ATF-3蛋白表达显著... 相似文献
2.
C. Vogrig J.-S. Louis F. Avila R. Gillet G. Hossu A. Blum-Moyse P.A. Gondim Teixeira 《Diagnostic and interventional imaging》2021,102(3):181-187
PurposeThe purpose of this study was to compare morphologic assessment and relaxometry of patellar hyaline cartilage between conventional sequences (fast spin-echo [FSE] T2-weighted fat-saturated and T2-mapping) and synthetic T2 short-TI inversion recovery (STIR) and T2 maps at 1.5 T magnetic resonance imaging (MRI).MethodThe MRI examinations of the knee obtained at 1.5 T in 49 consecutive patients were retrospectively studied. There were 21 men and 28 women with a mean age of 45 ± 17.7 (SD) years (range: 18–88 years). Conventional and synthetic acquisitions were performed, including T2-weighted fat-saturated and T2-mapping sequences. Two radiologists independently compared patellar cartilage T2-relaxation time on conventional T2-mapping and synthetic T2-mapping images. A third radiologist evaluated the patellar cartilage morphology on conventional and synthetic T2-weighted images. The presence of artifacts was also assessed. Interobserver agreement for quantitative variables was assessed using intraclass correlation coefficient (ICC).ResultsIn vitro, conventional and synthetic T2 maps yielded similar mean T2 values 58.5 ± 2.3 (SD) ms and 58.8 ± 2.6 (SD) ms, respectively (P = 0.414) and 6% lower than the expected experimental values (P = 0.038). Synthetic images allowed for a 15% reduction in examination time compared to conventional images. On conventional sequences, patellar chondropathy was identified in 35 patients (35/49; 71%) with a mean chondropathy grade of 4.8 ± 4.8 (SD). On synthetic images, 28 patients (28/49; 57%) were diagnosed with patellar chondropathy, with a significant 14% difference (P = 0.009) and lower chondropathy scores (3.7 ± 4.9 [SD]) compared to conventional images. Motion artifacts were more frequently observed on synthetic images (18%) than on conventional ones (6%). The interobserver agreement was excellent for both conventional and synthetic T2 maps (ICC > 0.83). Mean cartilage T2 values were significantly greater on synthetic images (36.2 ± 3.8 [SD] ms; range: 29-46 ms) relative to conventional T2 maps (31.8 ± 4.1 [SD] ms; range: 26-49 ms) (P < 0.0001).ConclusionDespite a decrease in examination duration, synthetic images convey lower diagnostic performance for chondropathy, greater prevalence of motion artifacts, and an overestimation of T2 values compared to conventional MRI sequences. 相似文献
3.
4.
5.
6.
7.
Study designMeta-analysis.ObjectivesWe aim to analyze and compare the efficacy and safety of vehicle-based delivery of Mesenchymal Stromal Cells (MSCs) in the management of osteoarthritis of the knee from Randomized Controlled Trials (RCTs) available in the literature.Materials and methodsWe conducted independent and duplicate electronic database searches including PubMed, Embase, Web of Science, and Cochrane Library till August 2021 for RCTs analyzing the efficacy and safety of vehicle-based delivery of MSCs in the management of knee osteoarthritis. Visual Analog Score (VAS) for Pain, Western Ontario McMaster Universities Osteoarthritis Index (WOMAC), Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) score, and adverse events were the outcomes analyzed. Analysis was performed in R-platform using OpenMeta [Analyst] software.Results21 studies involving 936 patients were included for analysis. None of the studies made a direct comparison of the direct and vehicle-based delivery of MSCs, hence we pooled the results of all the included studies of both groups and made a comparative analysis of their outcomes. Although at 6 months, both direct and vehicle-based delivery of MSCs showed significantly better VAS improvement (p = 0.002, p = 0.010), it was not consistent at 1 year for the vehicle delivery (p = 0.973). During 6 months and 12 months, direct delivery of MSCs (p < 0.001, p < 0.001) outperformed vehicle delivery (p = 0.969, p = 0.922) compared to their control based on WOMAC scores respectively. Both direct (p = 0.713) and vehicle-based delivery (p = 0.123) of MSCs did not produce significant adverse events compared to their controls.ConclusionOur analysis of literature showed that current clinically employed methods of vehicle-based delivery of MSCs such as platelet-rich plasma, hyaluronic acid did not demonstrate superior results compared to direct delivery, concerning the efficacy of treatment measured by improvement in pain, functional outcomes, and safety. Hence, we urge future clinical trials to be conducted to validate the effectiveness of advanced delivery vehicles such as composite bioscaffolds to establish their practical utility in cartilage regeneration with respect to its encouraging in-vitro evidence. 相似文献
8.
9.